252 related articles for article (PubMed ID: 37100035)
1. Dupilumab-Associated Psoriasis and Psoriasiform Manifestations: A Scoping Review.
Su Z; Zeng YP
Dermatology; 2023; 239(4):646-657. PubMed ID: 37100035
[TBL] [Abstract][Full Text] [Related]
2. Dupilumab-associated psoriasis and psoriasiform dermatitis in patients with atopic dermatitis.
Casale F; Nguyen C; Dobry A; Smith J; Mesinkovska NA
Australas J Dermatol; 2022 Aug; 63(3):394-397. PubMed ID: 35460570
[No Abstract] [Full Text] [Related]
3. Psoriasiform dermatitis during dupilumab treatment for moderate-to-severe atopic dermatitis in children.
Parker JJ; Sugarman JL; Silverberg NB; Gonzalez ME; Ramien ML; Teng JMC; Paller AS
Pediatr Dermatol; 2021 Nov; 38(6):1500-1505. PubMed ID: 34647354
[TBL] [Abstract][Full Text] [Related]
4. A pediatric case of dupilumab-induced pustular psoriasis.
Dang N; Zheng H; Ren Y
J Dermatolog Treat; 2024 Dec; 35(1):2333016. PubMed ID: 38839072
[TBL] [Abstract][Full Text] [Related]
5. Pustular Psoriasis Appearing Induced by Dupilumab Therapy in a Patient With Atopic Dermatitis.
Jia X; Li C; Wu J; Liu Q
J Drugs Dermatol; 2022 Mar; 21(3):311-312. PubMed ID: 35254760
[TBL] [Abstract][Full Text] [Related]
6. Paradoxical tralokinumab-induced psoriasis in a patient with atopic dermatitis.
Balakirski G; Burmann SN; Hofmann SC; Kreuter A
J Dermatolog Treat; 2023 Dec; 34(1):2258240. PubMed ID: 37705378
[No Abstract] [Full Text] [Related]
7. Psoriasiform Dermatitis After Initiation of Treatment with Dupilumab for Atopic Dermatitis.
Fowler E; Silverberg JI; Fox JD; Yosipovitch G
Dermatitis; 2019; 30(3):234-236. PubMed ID: 31094943
[No Abstract] [Full Text] [Related]
8. Occurrence of psoriasiform eruption during dupilumab therapy for adult atopic dermatitis: A case series.
Napolitano M; Scalvenzi M; Fabbrocini G; Cinelli E; Patruno C
Dermatol Ther; 2019 Nov; 32(6):e13142. PubMed ID: 31664761
[No Abstract] [Full Text] [Related]
9. [Psoriasis in dupilumab-treated atopic dermatitis].
Senner S; Eicher L; Aszodi N; Prinz JC; French LE; Wollenberg A
Hautarzt; 2020 May; 71(5):383-386. PubMed ID: 32179945
[TBL] [Abstract][Full Text] [Related]
10. Psoriasis-like Dermatitis Developing in a Patient with Atopic Dermatitis Treated with Dupilumab.
Stout M; Guitart J; Tan T; Silverberg JI
Dermatitis; 2019; 30(6):376-378. PubMed ID: 31609853
[No Abstract] [Full Text] [Related]
11. Weight gain in patients with severe atopic dermatitis treated with dupilumab: a cohort study.
Johansson EK; Ivert LU; Bradley B; Lundqvist M; Bradley M
BMC Dermatol; 2020 Sep; 20(1):8. PubMed ID: 32962676
[TBL] [Abstract][Full Text] [Related]
12. Rosacea associated with dupilumab therapy.
Heibel HD; Hendricks AJ; Foshee JP; Shi VY
J Dermatolog Treat; 2021 Feb; 32(1):114-116. PubMed ID: 31132923
[No Abstract] [Full Text] [Related]
13. Acute onset of psoriasis in a patient with atopic dermatitis treated with dupilumab.
Ferrucci S; Tavecchio S; Berti E; Angileri L
Clin Exp Dermatol; 2020 Jul; 45(5):625-626. PubMed ID: 32112580
[No Abstract] [Full Text] [Related]
14. Dupilumab in the treatment of moderate-to-severe atopic dermatitis.
Kraft M; Worm M
Expert Rev Clin Immunol; 2017 Apr; 13(4):301-310. PubMed ID: 28165826
[TBL] [Abstract][Full Text] [Related]
15. Safety of dupilumab in a 5-month-old infant with severe atopic dermatitis.
Havele SA; Khurana MC; McMahon P; Murthy AS; Perman MJ; Treat JR
Pediatr Dermatol; 2022 Mar; 39(2):291-294. PubMed ID: 35434859
[TBL] [Abstract][Full Text] [Related]
16. Dupilumab-associated ocular manifestations: A review of clinical presentations and management.
Wu D; Daniel BS; Lai AJX; Wong N; Lim DKA; Murrell DF; Lim BXH; Mehta JS; Lim CHL
Surv Ophthalmol; 2022; 67(5):1419-1442. PubMed ID: 35181280
[TBL] [Abstract][Full Text] [Related]
17. Ocular surface disease associated with dupilumab treatment for atopic diseases.
Utine CA; Li G; Asbell P; Pflugfelder S; Akpek E
Ocul Surf; 2021 Jan; 19():151-156. PubMed ID: 32439390
[TBL] [Abstract][Full Text] [Related]
18. Dupilumab-induced phenotype switch from atopic dermatitis to psoriasis is characterized by de novo interleukin-17A expression: a case report.
Mirza FN; Wang A; Ramachandran SM; Damsky W; Cohen JM
Br J Dermatol; 2021 Aug; 185(2):432-434. PubMed ID: 33730377
[No Abstract] [Full Text] [Related]
19. Safety of dupilumab in patients with atopic dermatitis: expert opinion.
Francuzik W; Alexiou A; Worm M
Expert Opin Drug Saf; 2021 Sep; 20(9):997-1004. PubMed ID: 34114910
[No Abstract] [Full Text] [Related]
20. Long-Term Efficacy and Safety of Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Phase III Open-Label Extension Trial (LIBERTY AD PED-OLE).
Blauvelt A; Guttman-Yassky E; Paller AS; Simpson EL; Cork MJ; Weisman J; Browning J; Soong W; Sun X; Chen Z; Kosloski MP; Kamal MA; Delevry D; Chuang CC; O'Malley JT; Bansal A
Am J Clin Dermatol; 2022 May; 23(3):365-383. PubMed ID: 35567671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
